Elusys Therapeutics is dedicated to delivering innovative medical countermeasures that enable fast, effective, and durable protection against infectious agents. Our goal is to accelerate the development and commercialization of novel biodefense solutions, such as our anthrax antitoxin ANTHIM® (obiltoxaximab), for strategic government partners.

Government

Life Sciences

Medical Devices

Therapeutics

Elusys Therapeutics, Inc.

Jeremy Middleton

Vera Wong

Jennifer White

Matthew M. Seavey

Ryan Michalek

Lawrence Gyenes

Bob Love

Elusys Therapeutics, Inc.

Org chart

Teams

Similar companies